Recombinant Macaca fascicularis 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (SRD5A1)

What is SRD5A1 and what are its primary functions in mammalian physiology?

SRD5A1 (3-oxo-5-alpha-steroid 4-dehydrogenase 1) is a steroidogenic enzyme responsible for the conversion of testosterone to dihydrotestosterone (DHT), which is essential for healthy ovarian follicle growth. In the brain, this enzyme catalyzes the production of neurosteroids by converting deoxycorticosterone and progesterone to their 5α-reduced forms. These are subsequently converted to tetrahydrodeoxycorticosterone and allopregnanolone, which regulate the hypothalamic-pituitary-adrenal and gonadal axes . SRD5A1 plays important roles in stress response and likely contributes to early life programming of these endocrine axes. The enzyme is expressed in multiple tissues including skin, hypothalamus, and ovaries, with expression patterns that vary throughout development .

Methodologically, when studying SRD5A1 function across species, researchers should consider tissue-specific expression patterns and developmental stages, as these factors significantly impact enzyme activity and physiological outcomes. Experiments should be designed to account for these variables by carefully selecting appropriate developmental timepoints and conducting parallel analyses across multiple tissues of interest.

What is the molecular structure of SRD5A1, and how does it influence function?

The molecular structure of SRD5A1 reflects its membrane-bound nature and enzymatic function. The full-length cDNA sequence typically contains an ORF of approximately 795 bp, translating into 265 amino acids . Signal peptide analysis reveals that SRD5A1 is a non-secretory protein with a hydrophobic nature, consistent with its membrane localization .

Three-dimensional structural analysis shows that SRD5A1 contains seven transmembrane helices connected by six loops, with the N-termini located on the periplasmic side and C-termini on the cytosolic side . Electrostatic potential calculations reveal a large cavity with two openings: one highly electropositive facing the cytosolic side and another relatively neutral towards the transmembrane region . This structural arrangement facilitates binding of NADPH at the electropositive side and steroid hormone substrates in the hydrophobic environment.

Critical functional residues include E66 and Y101, which are conserved and involved in hydrogen bonding with the ketone group at C-3 in steroids, facilitating Δ4 double-bond reduction . These structural characteristics directly influence the enzyme's substrate specificity and catalytic efficiency.

How is SRD5A1 expression regulated during development and across different tissues?

SRD5A1 expression demonstrates dynamic tissue-specific regulation throughout development. In murine ovaries, SRD5A1 mRNA expression increases approximately 8-fold between postnatal days 10 and 30, coinciding with rising estradiol (E2) levels during the prepubertal stage . This developmental pattern correlates with decreasing methylation of specific CpG sites in the first intron of the gene, with methylation decreasing by up to 75% during this period .

In contrast, hypothalamic preoptic area (POA) expression follows a different pattern, with SRD5A1 mRNA levels decreasing by 70% between postnatal days 7 and 10 and then remaining relatively constant . Unlike in ovarian tissue, this change does not correlate with CpG methylation levels in the POA.

The regulatory mechanisms also differ between tissues. In ovarian cells, estradiol exposure increases SRD5A1 expression, while in hypothalamic cells, glucocorticoids (such as dexamethasone) reduce expression levels . These tissue-specific differences highlight the importance of context when studying SRD5A1 regulation.

What experimental techniques are most effective for studying recombinant SRD5A1 expression?

When expressing and studying recombinant SRD5A1, several methodological approaches have proven effective. For expression analysis, quantitative RT-PCR using validated primer sets is recommended, with multiplexing capability demonstrated for SRD5A1 and housekeeping genes like cyclophilin . When designing primers, researchers should target conserved regions across species while accounting for any Macaca fascicularis-specific variations.

For protein expression and detection, epitope tagging approaches have proven valuable. Previous studies have successfully used V5-epitope tags at the C-terminus of SRD5A1, with detection via anti-V5 antibodies . This approach circumvents potential issues with commercially available SRD5A1 antibodies, which may have variable specificity across species.

Expression vector selection is crucial for successful recombinant expression. Plasmid vectors such as pcDNA/V5-His have been successfully employed for SRD5A1 expression in mammalian cells . Transformation protocols typically involve heat-shock methods (42°C for 45 seconds) when using competent bacterial cells for plasmid propagation.

For transfection into mammalian cells, lipid-based methods such as Lipofectamine 2000 have demonstrated efficacy, with optimal results achieved using approximately 0.5 μg of purified plasmid per transfection . Cell culture conditions should be optimized for the specific cell line, with media changes 24 hours before experimental treatments when studying hormone responses.

How do epigenetic mechanisms regulate SRD5A1 expression, and how can these be experimentally manipulated?

Epigenetic regulation of SRD5A1 involves complex methylation patterns that exhibit tissue specificity. While the promoter of SRD5A1 (encompassed by a CpG island) remains unmethylated in certain tissues, the "shore" in the 5′ end of the first intron shows variable methylation that correlates with expression levels . These shores, with lower CpG density at the margins of CpG islands, display methylation patterns that are often conserved across species and tissues, and are closely associated with transcriptional repression .

Experimental manipulation of SRD5A1 methylation can be achieved through targeted approaches. Chromatin immunoprecipitation (ChIP) assays have confirmed estrogen receptor (ESR1) binding to differentially methylated regions in ovarian cells, with enrichment of the enhancer modification H3K4me1 . The CRISPR-Cas9 system has been adapted for targeted epigenetic modifications, with dCas9-DNMT3 successfully increasing CpG methylation 2.5-fold at specific sites, abolishing estradiol-mediated SRD5A1 response . Conversely, dCas9-TET1 has been employed to reduce CpG methylation by approximately 50% .

When designing experiments to study SRD5A1 epigenetic regulation, researchers should carefully select cell lines that maintain tissue-specific regulatory mechanisms. For instance, the KK-1 granulosa cell line has been successfully used for ovarian SRD5A1 studies, while GT1-7 cells serve as an appropriate model for hypothalamic regulation . These methodological considerations ensure that observed epigenetic changes reflect physiologically relevant regulatory mechanisms.

What are the key considerations when comparing SRD5A1 function across different species, particularly between human and non-human primates?

Cross-species analysis of SRD5A1 requires careful consideration of evolutionary conservation and divergence. Structural studies using AlphaFold 2 predictions have demonstrated high structural similarity between bacterial, human, and other vertebrate SRD5A1 proteins, particularly in the transmembrane domains and catalytic regions . This conservation suggests functional similarity, but species-specific variations may influence substrate affinity and catalytic efficiency.

When comparing Macaca fascicularis SRD5A1 with human orthologs, researchers should focus on several key aspects:

• Sequence homology analysis of coding regions and regulatory elements

• Conservation of critical functional residues (e.g., E66 and Y101 for steroid binding)

• Expression patterns across comparable tissues and developmental stages

• Substrate specificity and enzyme kinetics

• Response to regulatory factors like steroids and stress hormones

Methodologically, comparative studies benefit from parallel analysis using identical experimental conditions. When designing primers or antibodies for cross-species studies, targeting highly conserved regions improves reliability. For functional comparisons, standardized enzyme activity assays using the same substrates and analytical methods ensure comparable results.

The presence of species-specific post-translational modifications or splice variants should be investigated, as these may contribute to functional differences despite high sequence conservation. For Macaca fascicularis specifically, researchers should account for potential differences in steroid metabolism pathways that may influence the physiological roles of SRD5A1.

How can SRD5A1 knockdown or inhibition be optimally achieved in research models?

Multiple approaches have been developed for effective SRD5A1 inhibition or knockdown, each with methodological considerations for optimal results. siRNA-mediated silencing has successfully reduced SRD5A1 transcripts to approximately 10% of control levels in human cell lines . When designing siRNA experiments, multiple target sequences should be tested to identify those with greatest knockdown efficiency, and effects should be confirmed at both mRNA and protein levels.

CRISPR-Cas9 approaches offer more permanent gene modification options, while epigenetic modulation using tools like dCas9-DNMT3 provides reversible regulation through methylation changes . The choice between these methods depends on research objectives and model systems, with consideration for potential compensatory mechanisms that may emerge with long-term inhibition.

What role does SRD5A1 play in pathological conditions, and how might recombinant SRD5A1 contribute to therapeutic development?

In reproductive disorders, SRD5A1 has been suggested to contribute to the pathogenesis of polycystic ovary syndrome, though evidence is still emerging . Its role in converting testosterone to DHT, required for healthy ovarian follicle growth, suggests that dysregulation could impact reproductive function .

Recombinant Macaca fascicularis SRD5A1 offers several potential applications in therapeutic development:

• As a screening platform for novel inhibitors with improved specificity

• For structural studies to identify species-specific binding interactions

• To investigate stereoselective metabolism of potential drug candidates

• For development of monoclonal antibodies targeting SRD5A1-overexpressing tumors

Methodologically, researchers developing therapeutic approaches should consider tissue-specific regulation patterns and potential compensatory mechanisms. For example, the differential regulation by estradiol in ovarian tissue versus glucocorticoid regulation in the hypothalamus necessitates tissue-targeted approaches . Therapeutic strategies should also account for the methylation-sensitive nature of SRD5A1 expression, as epigenetic modulators might offer alternative intervention approaches.

What are the most effective protocols for purification and functional characterization of recombinant Macaca fascicularis SRD5A1?

Purification of functional recombinant SRD5A1 presents technical challenges due to its hydrophobic nature and multiple transmembrane domains. Based on successful approaches with related proteins, the following methodological considerations are recommended:

Epitope tagging strategies, such as C-terminal V5 or polyhistidine tags, facilitate both detection and purification . For optimal results, the tag position should be carefully selected to minimize interference with protein folding or enzymatic activity. Dual tagging approaches (e.g., FLAG and His tags) can enable sequential purification steps for increased purity.

Detergent selection is critical for solubilization while maintaining enzymatic activity. Mild non-ionic detergents like DDM (n-dodecyl β-D-maltoside) or digitonin often provide a good balance between solubilization efficiency and protein stability. Nanodiscs or styrene-maleic acid lipid particles (SMALPs) represent alternative approaches for maintaining SRD5A1 in a near-native lipid environment.

Functional characterization requires assessing both binding affinity and catalytic activity. Radiolabeled substrate binding assays or surface plasmon resonance can evaluate substrate interactions, while HPLC or mass spectrometry-based methods can quantify conversion of testosterone to DHT or other relevant substrates. Thermal stability assays using differential scanning fluorimetry can assess protein quality and ligand interactions.